Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Heat Shock Protein Inhibitors
69 Products
69 Products
257 Diseases
2506 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
5
10
15
20
25
30
35
40
45
50
ganetespib
(ADX-1612) / Aldeyra
tanespimycin
(BMS-722782) / BMS
luminespib
(AUY922) / Ligand
RNS60
/ Revalesio
onalespib
(AT13387) / Otsuka
SNX-5422
/ Esanex
retaspimycin
(IPI-504) / Infinity Pharma
IMR-261
/ Enliven Therapeutics
apatorsen
(OGX-427) / Achieve Life Sciences
elesclomol
(STA-4783) / Madrigal Pharma
ND-L02-s0201
/ Nitto Denko, BMS
minnelide
/ Minneamrita Therap
icapamespib
(PU-AD) / Samus Therap
viagenpumatucel-L
(HS-110) / NightHawk Biosci
BGP-15
/ N-Gene
Jeselhy
(pimitespib) / Otsuka
Miplyffa
(arimoclomol) / Orphazyme, Zevra Therap
RGRN-305
/ Regranion, MC2 Therap
zelavespib intravenous
(PU-H71 IV) / Samus Therap
XL888
/ Exelixis, Merck (MSD)
AZX 100
/ Capstone
BOLD-100
/ Bold Therap
IPI 493
/ Innate
JIN-001
/ J Ints Bio
KW 2478
/ Kyowa Kirin
PAT-SM6
/ Patrys
carbon monoxide
(HBI-002) / Hillhurst Biopharma
cemdomespib
(RTA 901) / Biogen
locnartecan
(PEN-866) / Tarveda Therap, National Cancer Institute - Bethesda
CSL889 hemopexin
/ CSL Behring
CXA-10 IV
/ Complexa
DS-2248
/ Daiichi Sankyo
LAM 003
/ OrphAI Therap
TQB3474
/ Sino Biopharm
brivudine
(RP 101) / RESprotect, RedHill, SciClone
gamitrinib
/ Fox Chase Cancer Center, The Wistar Institute
recombinant human Hsp110-gp100 chaperone complex vaccine
/ National Cancer Institute, Roswell Park Comprehensive Cancer Center
zelavespib oral
(PU-H71 oral) / Samus Therap
